NSUN2 rs13181449 variant decreases the risk of oral cancer development
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.113676 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Li-Chung Hung und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Methyltransferases, Squamous Cell Carcinoma of Head and Neck. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
NOP2/Sun RNA methyltransferase 2 (NSUN2), encoded by the NSUN2 gene, is a nuclear RNA methyltransferase that catalyzes the methylation of cytosine to 5-methylcytosine (m5C). Although RNA modification has been widely discussed in cancer development and prognosis, the role of the NSUN2 gene in oral cavity squamous cell carcinoma (OCSCC) is unclear. This was a retrospective, case-control study. A total of 2514 participants were enrolled, including 52.4% (1318/2514) diagnosed with OCSCC and others as health control. The impact of NSUN2 rs4702373, rs166049, rs13181449, and rs8192120 on cancer development and prognosis were analyzed. Our results revealed that NSUN2 rs13181449 allele TT was significantly associated with lower OCSCC risk, with an adjusted odd ratio (AOR) [95% confidence index (CI)] of 0.757[0.575-0.997]. For cigarette smokers, the impact of rs13181449 was more obvious that AOR [95% CI] of allele CT, TT, and CT+TT were 0.760 [0.583-0.991], 0.699 [0.493-0.990], 0.746 [0.580-0.960], respectively. For OCSCC patients, rs4702373 allele CT was independently associated with advanced histological grade. Expression levels between different allele mutations were various in the GTE database. Mutant rs4702373 and rs166049 were associated with higher expression than the wild type, conversely mutant rs13181449 had lower expression. In the TCGA database, the trend that patients with higher expression had worse survival than those with lower expression was shown. In conclusion, NSUN2 rs13181449 was associated with lower cancer risk, especially for cigarette smokers. Unlikely other allele mutations, rs13181449 was correlated to lower expression. Patients with higher expression had worsened clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Department of Otolaryngology, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Department of Otolaryngology, St. Martin De Porres Hospital, Chiayi, Taiwan.
- Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
Zitieren
APA
Hung, L. C., Huang, C. C., Lu, Y. T., Su, C. W., Lin, C. W., Chu, H. J., Yang, S. F., & Lu, H. J. (2025). NSUN2 rs13181449 variant decreases the risk of oral cancer development. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.113676
Vancouver
Hung LC, Huang CC, Lu YT, Su CW, Lin CW, Chu HJ, et al. NSUN2 rs13181449 variant decreases the risk of oral cancer development. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.113676
BibTeX
@article{Hung2025,
author = {Hung, Li-Chung and Huang, Cheng-Chen and Lu, Yen-Ting and Su, Chun-Wen and Lin, Chiao-Wen and Chu, Hsiao-Ju and Yang, Shun-Fa and Lu, Hsueh-Ju},
title = {NSUN2 rs13181449 variant decreases the risk of oral cancer development},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.113676}
}
EUVIMED